PENTAX-MEDICAL
28.11.2014 11:01:31 CET | Business Wire | Pressemeddelelse
PENTAX Medical launches today the new VIVIDEO system, an advanced ENT videoscope solution, in the European, Middle Eastern and African (EMEA) Markets. This endoscopy system consists of a video processor and video naso-pharyngo-laryngoscope (CP-1000 and VNL9-CP).
The new VIVIDEO solution brings to market a high quality and affordable High-Definition (HD) video naso-pharyngo-laryngoscope, allowing fiber endoscopy users to affordably transition their practice to video endoscopy. This new easy-to-use technology delivers superior performance and image quality to enhance diagnostic yield and improve patient care.
Due to its exceptional HD image quality and enhanced illumination, the VIVIDEO system enables high quality diagnostic examinations in all ENT environments. Its integrated HD video recording will capture and document clinical findings for documentation and comparison.
The VIVIDEO solution contributes to enhanced patient care by providing rapid diagnosis through effective and high quality examinations. This reduces patient uncertainty and ensures earlier treatment if required. Maximum patient comfort is also ensured due to the extremely small diameter insertion tube of just 3mm. Furthermore, its unique insertion tube flexibility and ergonomic, lightweight handle enables smooth and convenient procedures for improved work flow, enabling increased patient throughput and outstanding price-performance.
Commenting on the image quality of VIVIDEO, Dr. Guido Van Den Broek, from Nijmegen, Netherlands, said “Compared to fiber scopes, the image and illumination is a different world.” Gary R. Wood BSc from London, UK, adds his first experiences towards patient comfort: “I had a patient that said: It is the first time I have been scoped and never felt it.”
The new VIVIDEO solution is officially launched in Augsburg, Germany, to an exclusive invited audience of ENT physicians from EMEA who are the first to view and experience the new videoscope. “We are very excited to be the first region to launch this superb product. Based on the enthusiastic feedback from the first users, we believe it will have a significant impact on the patient care, diagnostic yield and performance for the ENT market in EMEA,” said Dr. Ismaël Nujurally, President EMEA, PENTAX Medical.
In addition, the invited group has the chance to visit Digital Endoscopy GmbH, also located in Augsburg. This imaging technology center was acquired by PENTAX Medical´s parent company, Hoya Corporation in 2012 as PENTAX Medical´s European R&D center. Since then, the synergies of advanced imaging technology are already resulting in the expansion of an innovative product pipeline. The VIVIDEO ENT Endoscopic Solution is the first global product to be designed and manufactured in this new European-based facility.
“The launch of VIVIDEO is yet another illustration of PENTAX Medical's commitment to improving the clinical and economic value of our products for our customers. The launch of VIVIDEO also marks a milestone in PENTAX Medical's journey to develop products based on the needs and requirements of our worldwide base of existing and prospective customers,” said Ganesh Ramaswamy, Global President of PENTAX Medical.
About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. For more information, please visit: www.pentaxmedical.com .
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20141128005030/en/
Contact:
PENTAX Europe GmbH
Katharina Meitzler, +49-40-56192-0
Project
Manager Marketing Communications
katharina.meitzler@pentaxmedical.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum